cyclosporine has been researched along with Encephalopathy, Traumatic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 8 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HR; Kim, MS; Kim, YH; Kwon, B | 1 |
| Elmér, E; Hansson, MJ | 1 |
| Chen, H; Chen, L; Chen, Y; Feng, J; Gao, X; Huang, J; Jiang, G; Jiang, J; Meng, S; Song, Q; Zhang, Q; Zheng, M | 1 |
| Beskonakli, E; Celikmez, RC; Eroglu, H; Gurcan, O; Oner, L; Taskin, Y; Turkoglu, OF; Uckun, MO | 1 |
| Asante, I; Black, CE; DeAngelo, C; Humayun, M; Louie, SG; Petasis, NA; Yang, R; Zhou, E | 1 |
| Begemann, M; Leon, M; Sommer, I; van der Horn, HJ; van der Naalt, J | 1 |
| Chawla, S; Delso, N; Ehinger, J; Elmér, E; Hansson, MJ; Hugerth, M; Karlsson, M; Kilbaugh, TJ; Margulies, SS; Pukenas, B; Wang, KKW; Yang, Z | 1 |
| Geddes, JW; Hubbard, WB; Kalimon, OJ; Readnower, RD; Sullivan, PG | 1 |
| Cebak, JE; Hall, ED; Kulbe, JR; Singh, IN; Wang, JA | 1 |
| Åstrand, R; Elmér, E; Fischer, W; Hansson, MJ; Hugerth, M; Juhler, M; Karlsson, M; Keep, MF; Kelsen, J; Kilbaugh, T; Møller, K; Nordström, CH; Wang, KKW; Yang, Z | 1 |
| Bramlett, HM; Deng-Bryant, Y; Dietrich, WD; Dixon, CE; Empey, PE; Hayes, RL; Kochanek, PM; Mondello, S; Povlishock, JT; Shear, DA; Tortella, FC; Wang, KK; Yan, HQ | 1 |
| Palzur, E; Shehadeh, M; Soustiel, JF; Vlodavsky, E | 1 |
| Colley, BS; Phillips, LL; Reeves, TM; Trimmer, PA | 1 |
| Hall, ED; Hill, RL; Kulbe, JR; Singh, IN; Wang, JA | 1 |
2 review(s) available for cyclosporine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Cyclosporine as Therapy for Traumatic Brain Injury.
Topics: Biomarkers; Brain Injuries; Brain Injuries, Traumatic; Cyclosporine; Humans; Neuroprotective Agents | 2023 |
Drugs with anti-inflammatory effects to improve outcome of traumatic brain injury: a meta-analysis.
Topics: Age Factors; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Cyclosporine; Erythropoietin; Humans; Progesterone; Treatment Outcome | 2020 |
1 trial(s) available for cyclosporine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients.
Topics: Adult; Biomarkers; Brain Injuries, Traumatic; Cyclosporine; Denmark; Female; Glasgow Coma Scale; Humans; Immunosuppressive Agents; Male; Middle Aged; Severity of Illness Index; Young Adult | 2019 |
11 other study(ies) available for cyclosporine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Efficacy and Safety of Early Anti-inflammatory Drug Therapy for Secondary Injury in Traumatic Brain Injury.
Topics: Animals; Body Weight; Brain Injuries, Traumatic; Cyclosporine; Cytokines; Dexamethasone; Disease Models, Animal; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases | 2023 |
Tailored Reconstituted Lipoprotein for Site-Specific and Mitochondria-Targeted Cyclosporine A Delivery to Treat Traumatic Brain Injury.
Topics: Animals; Brain Injuries, Traumatic; Cyclosporine; Humans; Lipoproteins; Mice; Mitochondria; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2020 |
Neuroprotective Efficiency of Cyclosporine After Traumatic Brain Injury in Rats.
Topics: Animals; Brain; Brain Edema; Brain Injuries, Traumatic; Cyclosporine; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2020 |
Cyanine Nanocage Activated by Near-IR Light for the Targeted Delivery of Cyclosporine A to Traumatic Brain Injury Sites.
Topics: Animals; Brain Injuries, Traumatic; Carbocyanines; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Liberation; Humans; Infrared Rays; Nanoparticles; Neuroprotective Agents; Photochemotherapy; Rats | 2020 |
Evaluation of Diffusion Tensor Imaging and Fluid Based Biomarkers in a Large Animal Trial of Cyclosporine in Focal Traumatic Brain Injury.
Topics: Animals; Animals, Newborn; Biomarkers; Brain Injuries, Traumatic; Cyclosporine; Diffusion Tensor Imaging; Female; Immunosuppressive Agents; Swine | 2021 |
Genetic Approach to Elucidate the Role of Cyclophilin D in Traumatic Brain Injury Pathology.
Topics: Animals; Brain Injuries, Traumatic; CA3 Region, Hippocampal; Cognition; Cyclosporine; Energy Metabolism; Memory; Mice, Knockout; Mitochondria; Neurons; Neuroprotection; Peptidyl-Prolyl Isomerase F | 2021 |
Continuous Infusion of Phenelzine, Cyclosporine A, or Their Combination: Evaluation of Mitochondrial Bioenergetics, Oxidative Damage, and Cytoskeletal Degradation following Severe Controlled Cortical Impact Traumatic Brain Injury in Rats.
Topics: Animals; Brain Injuries, Traumatic; Cyclosporine; Cytoskeleton; Energy Metabolism; Male; Mitochondria; Neuroprotective Agents; Oxidative Stress; Phenelzine; Rats; Rats, Sprague-Dawley | 2018 |
Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Topics: Animals; Biomarkers; Brain Injuries, Traumatic; Cyclosporine; Disease Models, Animal; Glial Fibrillary Acidic Protein; Immunosuppressive Agents; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Ubiquitin Thiolesterase | 2016 |
Post-traumatic cytotoxic edema is directly related to mitochondrial function.
Topics: Animals; Brain Edema; Brain Injuries, Traumatic; Cyclosporine; Intracranial Pressure; Mitochondria; Mitochondrial Membranes; Oligomycins; Rats; Rats, Sprague-Dawley | 2017 |
Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.
Topics: Action Potentials; Animals; Animals, Newborn; Brain Injuries, Traumatic; Calcium-Binding Proteins; Cells, Cultured; Clofazimine; Corpus Callosum; Cyclosporine; Disease Models, Animal; Electric Stimulation; Gene Expression Regulation; Immunosuppressive Agents; Kv1.3 Potassium Channel; Leukoencephalopathies; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Tacrolimus | 2016 |
Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A.
Topics: Animals; Brain Injuries, Traumatic; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Male; Mitochondria; Neuroprotective Agents; Rats, Sprague-Dawley; Synapses | 2017 |